Pharmacokinetics and tolerability of escalating single lorcaserin doses in male and female volunteers

Trial Profile

Pharmacokinetics and tolerability of escalating single lorcaserin doses in male and female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 21 May 2014

At a glance

  • Drugs Lorcaserin (Primary)
  • Indications Obesity; Overweight
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 May 2014 New trial record
    • 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top